Eagle Pharmaceuticals (OTC:EGRX) Stock, Earnings Estimates, EPS, And Revenue

Eagle Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date
Nov 8
EPS
Quarterly Revenue
Annual Revenue
(as of Jun 30)
$257.55M

Analyze the earnings history of Eagle Pharmaceuticals using advanced sorting and filters.

Data brought to you by Benzinga APIs

Eagle Pharmaceuticals (EGRX) Earnings Per Share

Quarterly Earnings Surprise Amount

Fiscal QuarterDate ReportedActual EPSEstimated EPSSurprise %
Q22023-08-08$1.18$1.0512.4 %
Q12023-05-09$1.26$1.0520.0 %
Q42023-03-13$1.10$0.8332.5 %
Q32022-11-07$1.12$0.9123.1 %

Eagle Pharmaceuticals (EGRX) Revenue

Quarterly Revenue Surprise Amount

Fiscal QuarterDate ReportedActual RevenueEstimated RevenueSurprise %
Q22023-08-08$64.65M$59.35M8.92 %
Q12023-05-09$66.31M$63.29M4.76 %
Q42023-03-13$60.70M$64.26M-5.54 %
Q32022-11-07$65.90M$62.08M6.15 %

FAQ

Q

When is Eagle Pharmaceuticals (OTCEM:EGRX) reporting earnings?

A

Eagle Pharmaceuticals (EGRX) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 8, 2023 for Q3.

Q

What were the latest earnings per share (EPS) for Eagle Pharmaceuticals (OTCEM:EGRX)?

A

Eagle Pharmaceuticals (EGRX) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 8, 2023 for Q3 and the Actual EPS was $0.00, which missed the estimate of $1.07.

Q

What were Eagle Pharmaceuticals’s (OTCEM:EGRX) revenues?

A

Eagle Pharmaceuticals (EGRX) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 8, 2023 for Q3 and the Actual Revenue was $0K, which missed the estimate of $64.5M.

Browse earnings estimates, EPS, and revenue on all stocks.